Marzieh Mohammadi
Overview
Explore the profile of Marzieh Mohammadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malek S, Jaafari M, Mahmoudi A, Mohammadi M, Malaekeh-Nikouei B
Int J Pharm
. 2025 Jan;
671:125213.
PMID: 39814242
Surgical resection and postoperative adjuvant chemotherapy have enhanced the outlook for breast cancer patients. However, tumor relapse and serious side effects of chemotherapy continue to impact patients' quality of life....
2.
Rahimi P, Farshbaf-Khalili A, Shahnazi M, Ostarahimi A, Mohammadi M
J Caring Sci
. 2024 Dec;
13(3):197-206.
PMID: 39624601
Introduction: Postpartum depression (PPD) is the most prevalent postpartum complication, significantly diminishing sexual function in marital life. It may result in visible developmental delays, social and interactive challenges in infants,...
3.
Esmail Nia G, Mohammadi M, Sharifizadeh M, Ghalamfarsa G, Bolhassani A
Braz J Infect Dis
. 2024 Aug;
28(5):103866.
PMID: 39163991
Human Immunodeficiency Virus (HIV) infection is among the most challenging issues in the healthcare system, presenting significant financial and hygiene problems with a wide range of clinical manifestations. Despite the...
4.
Hatami H, Rahiman N, Mohammadi M
Int J Biol Macromol
. 2024 Apr;
267(Pt 2):131401.
PMID: 38582467
Oligonucleotide-based nanogels, as nascent biomaterials, possess several unique functional, structural, and physicochemical features with excellent drug-loading capacity and high potential for cancer gene therapy. Ongoing studies utilizing oligonucleotide-based nanogels hold...
5.
Jahani A, Nourbakhsh M, Ebrahimzadeh M, Mohammadi M, Yari D, Moradi A
Arch Bone Jt Surg
. 2024 Feb;
12(2):92-101.
PMID: 38420521
Osteoarthritis (OA) can arise from various factor including trauma, overuse, as well as degeneration resulting from age or disease. The specific treatment options will vary based on the severity of...
6.
Fadaei M, Mohammadi M, Fadaei M, Jaafari M
Expert Opin Drug Deliv
. 2023 Oct;
20(10):1387-1413.
PMID: 37791986
Introduction: Diabetes mellitus is one of the challenging health problems worldwide. Multiple daily subcutaneous injection of insulin causes poor compliance in patients. Development of efficient oral formulations to improve the...
7.
Saberi A, Kouhjani M, Mohammadi M, Hosta-Rigau L
J Nanobiotechnology
. 2023 Sep;
21(1):351.
PMID: 37770928
Despite the recent advances in the development of bone graft substitutes, treatment of critical size bone defects continues to be a significant challenge, especially in the elderly population. A current...
8.
Rahimi A, Karimipoor M, Mahdian R, Alipour A, Hosseini S, Mohammadi M, et al.
Iran J Biotechnol
. 2023 May;
21(2):e3388.
PMID: 37228627
Background: Despite recent advances in recombinant biotherapeutics production using CHO cells, their productivity remains lower than industrial needs, mainly due to apoptosis. Objectives: Present study aimed to exploit CRISPR/Cas9 technology...
9.
Mohammadi M, Bergh A, Jahdi N, Valizadeh L, Hosseini M, Hakimi S
BMC Health Serv Res
. 2023 May;
23(1):436.
PMID: 37143074
Background: This study describes the launching of a unit for continuous kangaroo mother care (KMC) in a teaching hospital (Taleghani) in Iran. Methods: We used a participatory three-stage action research...
10.
Karimi M, Kamali H, Fakhrmohammadi S, Khezri E, Malaekeh-Nikouei B, Mohammadi M
Int J Pharm
. 2023 Apr;
639:122947.
PMID: 37044227
Exploring efficient strategies to eradicate the tumor tissue and enhance patient outcomes still remained a serious challenge. Systemic toxicity of the current chemotherapeutics and their low concentration in the tumor...